<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>FDAApproved &#8211; News Journos</title>
	<atom:link href="https://newsjournos.com/tag/fdaapproved/feed/" rel="self" type="application/rss+xml" />
	<link>https://newsjournos.com</link>
	<description>Independent News and Headlines</description>
	<lastBuildDate>Mon, 17 Nov 2025 01:55:50 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://newsjournos.com/wp-content/uploads/2025/02/cropped-The_News_Journos_Fav-1-32x32.png</url>
	<title>FDAApproved &#8211; News Journos</title>
	<link>https://newsjournos.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>New FDA-Approved Eye Drops Target Age-Related Vision Problems in Adults</title>
		<link>https://newsjournos.com/new-fda-approved-eye-drops-target-age-related-vision-problems-in-adults/</link>
					<comments>https://newsjournos.com/new-fda-approved-eye-drops-target-age-related-vision-problems-in-adults/?noamp=mobile#respond</comments>
		
		<dc:creator><![CDATA[News Editor]]></dc:creator>
		<pubDate>Mon, 17 Nov 2025 01:55:49 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[AgeRelated]]></category>
		<category><![CDATA[Chronic Illness]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Disease Prevention]]></category>
		<category><![CDATA[Drops]]></category>
		<category><![CDATA[Exercise Routines]]></category>
		<category><![CDATA[Eye]]></category>
		<category><![CDATA[FDAApproved]]></category>
		<category><![CDATA[Fitness]]></category>
		<category><![CDATA[Health Technology]]></category>
		<category><![CDATA[Health Tips]]></category>
		<category><![CDATA[Healthcare Policy]]></category>
		<category><![CDATA[Healthcare Reform]]></category>
		<category><![CDATA[Healthy Eating]]></category>
		<category><![CDATA[Healthy Lifestyle]]></category>
		<category><![CDATA[Immunization]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Mental Health]]></category>
		<category><![CDATA[Mental Wellbeing]]></category>
		<category><![CDATA[Nutrition]]></category>
		<category><![CDATA[Patient Care]]></category>
		<category><![CDATA[problems]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Stress Management]]></category>
		<category><![CDATA[Target]]></category>
		<category><![CDATA[Vision]]></category>
		<category><![CDATA[Wellness]]></category>
		<guid isPermaLink="false">https://newsjournos.com/new-fda-approved-eye-drops-target-age-related-vision-problems-in-adults/</guid>

					<description><![CDATA[<p>This article is published by News Journos</p>
<p>A new FDA-approved eye drop named Vizz has entered the market, offering hope for individuals suffering from presbyopia, commonly known as age-related blurry vision. Manufactured by LENZ Therapeutics, these prescription eye drops claim to improve vision for up to 10 hours with just one application per day. Eye care professionals are advising patients to consult [...]</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></description>
										<content:encoded><![CDATA[<p>This article is published by News Journos</p>
<div id="">
<p style="text-align:left;">A new FDA-approved eye drop named Vizz has entered the market, offering hope for individuals suffering from presbyopia, commonly known as age-related blurry vision. Manufactured by LENZ Therapeutics, these prescription eye drops claim to improve vision for up to 10 hours with just one application per day. Eye care professionals are advising patients to consult them before using these drops, as it may not be a one-size-fits-all solution, particularly for older adults.</p>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left; padding:5px;">
          <strong>Article Subheadings</strong>
        </th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left; padding:5px;">
          <strong>1)</strong> Overview of Vizz and Its Benefits
        </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
          <strong>2)</strong> How Vizz Works
        </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
          <strong>3)</strong> Pricing and Availability
        </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
          <strong>4)</strong> Side Effects and Considerations
        </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
          <strong>5)</strong> Expert Opinions on Vizz
        </td>
</tr>
</tbody>
</table>
<h3 style="text-align:left;">Overview of Vizz and Its Benefits</h3>
<p style="text-align:left;">Vizz is a newly FDA-approved eye drop specifically designed to address the challenges posed by presbyopia. This common condition typically affects those over the age of 40, making it increasingly difficult to focus on close objects. With just one drop applied to each eye, Vizz is touted to enhance vision for up to 10 hours, potentially alleviating the need for reading glasses for many users. The introduction of this drug signifies a significant advancement in eye care, specifically targeting age-related vision decline.</p>
<h3 style="text-align:left;">How Vizz Works</h3>
<p style="text-align:left;">The mechanism of Vizz is quite fascinating. According to experts, these eye drops function similarly to adjusting the focus on a camera lens. When applied, they cause the iris—the colored part of the eye—to constrict, effectively reducing the size of the pupil. As the pupil narrows, it enhances the depth of focus, resembling the effect of looking through a pinhole. This makes it easier for individuals to see clearly at close distances, providing a temporary fix for presbyopia symptoms.</p>
<p style="text-align:left;">Dr. <strong>Robert Johnson Jr.</strong>, who has extensive experience in eye care, emphasizes that Vizz and its predecessor, Vuity, share similar structural functionalities. This innovative approach allows for improved focusing capabilities for those affected by this common condition.</p>
<h3 style="text-align:left;">Pricing and Availability</h3>
<p style="text-align:left;">Vizz is priced at approximately $79 for a month’s supply, which includes 25 doses. For patients needing a longer-term solution, a three-month supply—which contains 75 doses—can be purchased for around $198. However, it is important to note that prices may vary depending on the pharmacy where the eye drops are obtained. With its prescription-only status, individuals interested in trying Vizz will need to consult their eye care professionals to determine suitability.</p>
<h3 style="text-align:left;">Side Effects and Considerations</h3>
<p style="text-align:left;">While Vizz appears to be a promising solution for many, it is not without potential side effects. Users may experience eye redness, headaches, or dimmed vision after application. Dr. Johnson cautions that these drops are not a panacea for presbyopia; they should be viewed as a supplementary method in managing age-related vision deterioration. He notes that Vizz is likely to work better for patients in their 40s and 50s, whose focusing abilities are less compromised than those in their 60s or beyond.</p>
<p style="text-align:left;">As Dr. Johnson elaborates, “By the time you get to be my age, your natural ability to focus is all gone.” This reality indicates the varying effectiveness of such treatments based on age, highlighting that Vizz may not provide the same benefits to older individuals.</p>
<h3 style="text-align:left;">Expert Opinions on Vizz</h3>
<p style="text-align:left;">Healthcare professionals are unanimously advocating for patients to seek advice from their eye care providers prior to using Vizz. It&#8217;s crucial for individuals to assess their unique vision conditions and understand whether Vizz is an appropriate choice for them. Dr. Johnson recommends understanding the intended use and limitations of the drug before deciding to incorporate it into a daily regimen.</p>
<p style="text-align:left;">In summary, while Vizz presents an innovative option for dealing with presbyopia, patient education and professional consultation remain essential. The success of these eye drops may vary based on individual health nuances, particularly age and existing vision issues.</p>
<table style="width:100%; text-align:left;">
<thead>
<tr>
<th style="text-align:left;"><strong>No.</strong></th>
<th style="text-align:left;"><strong>Key Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">1</td>
<td style="text-align:left;">Vizz is a new FDA-approved eye drop for presbyopia, improving vision for up to 10 hours.</td>
</tr>
<tr>
<td style="text-align:left;">2</td>
<td style="text-align:left;">The drops work by causing the iris to constrict, enhancing depth of focus.</td>
</tr>
<tr>
<td style="text-align:left;">3</td>
<td style="text-align:left;">Cost for Vizz is approximately $79 for 25 doses and $198 for 75 doses.</td>
</tr>
<tr>
<td style="text-align:left;">4</td>
<td style="text-align:left;">Potential side effects include eye redness, headaches, and dimmed vision.</td>
</tr>
<tr>
<td style="text-align:left;">5</td>
<td style="text-align:left;">Consulting with an eye care professional is advised before using Vizz.</td>
</tr>
</tbody>
</table>
<h2 style="text-align:left;">Summary</h2>
<p style="text-align:left;">In conclusion, Vizz represents a significant development in the management of presbyopia, offering relief to individuals dealing with age-related vision decline. Although promising, it is essential for potential users to understand its limitations and consult their eye care providers prior to use. As the landscape of eye care continues to evolve, tools like Vizz may help many regain clarity in their daily lives.</p>
<h2 style="text-align:left;">Frequently Asked Questions</h2>
<p>  <strong>Question: What is Vizz?</strong></p>
<p style="text-align:left;">Vizz is a newly FDA-approved eye drop formulated to treat presbyopia, improving near vision for a duration of up to 10 hours with just one application.</p>
<p>  <strong>Question: Who is most likely to benefit from using Vizz?</strong></p>
<p style="text-align:left;">Younger individuals in their 40s and 50s are more likely to experience significant benefits from Vizz as their natural focusing abilities remain more intact compared to older patients.</p>
<p>  <strong>Question: What should I do if I experience side effects from Vizz?</strong></p>
<p style="text-align:left;">If you experience side effects such as eye redness or headaches after using Vizz, it is crucial to consult your eye care professional for guidance and possible alternative solutions.</p>
</div>
<p>©2025 News Journos. All rights reserved.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://newsjournos.com/new-fda-approved-eye-drops-target-age-related-vision-problems-in-adults/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
